Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.90 per share which beat the analyst consensus estimate of $2.86 by 1.4 percent. This is a 6.45 percent decrease over earnings of $3.10 per share from the same period last year. The company reported quarterly sales of $667.50 million which missed the analyst consensus estimate of $679.30 million by 1.74 percent. This is a 2.01 percent decrease over sales of $681.18 million the same period last year.